
Sign up to save your podcasts
Or


Subscriber-only episode
Episode 382: DACA recipient & Lawyer Edgar Rodriguez, Esq, joins David Capablanca on the Macro Jabber podcast to talk about financial literacy, investing with the goal of Edgar learning to trade stocks.
Social Media
Edgar Rodriguez
Instagram: erimmigrationlawyer
www.erimmigration.com
Send us a text
Friendly Bear UniversitySubscriber-only episode
Send us a text
Friendly Bear UniversitySubscriber-only episode
Send us a text
Friendly Bear UniversitySend us Fan Mail
Pulse Biosciences [NASDAQ: PLSE] is a medical device company with one product – the CellFX system. PLSE’s history is full of failure and wasted investors’ money trying to sell its technology for skin treatments. With the same team and approach, failure is going to repeat in the company’s pivot to cardiac ablation, or the Pulsed Field Ablation (PFA) market.
PLSE is years behind Boston Scientific (Farapulse) and Medtronic (Affera and PulseSelect) in the clinical studies/FDA approval process for PFA. Farapulse’s first clinical study was launched in 2018, over five years ago.
While nano pulse PFA technology was patented by Farapulse, Farapulse does not use nano pulse. PLSE is developing nano pulse PFA technology, and could be infringing on Farapulse’s patents. Medtronic and Abbott also choose to not develop nano pulse because evidence shows it’s inferior to micro pulse.
PLSE is desperately trying to deceive investors that they are close to commercial revenue with their ablation clamp by failing to disclose that comparable clamps had to receive PMA approval from the FDA with large clinical studies performed in order to be adopted by cardiac surgeons.
Pulse Biosciences Short Report
Support the show
Subscriber-only episode
Send us a text
Friendly Bear UniversitySubscriber-only episode
Send us a text
Friendly Bear UniversitySend us Fan Mail
Episode 381: James Kosinski, one of the representatives from Ortex's London office joins David Capablanca to break down all the key features on how short sellers of small cap stocks can use Ortex. For those interested in Ortex, you can email them for 10% off the annual subscription at [email protected]
Ortex brings you the most timely and accurate Short interest data available. Ortex short interest data is sourced from the worlds largest combined pool of agent lenders, prime brokers, and broker-dealers who submit their inventory. Ortex provides intra day and historical data for days to cover, shares on loan, utilization rate, cost of borrow and freefloat on loan. Ortex also provide all relevant US exchange data and relevant institutional short holdings flags so users can access all the information available in one place.
Social Media
Ortex
Twitter: ortex
www.ortex.com
Support the show
Send us Fan Mail
Episode 380: Market Wizard Victor Sperandeo joins David Capablanca on the Friendly Bear Podcast to discuss his experiences from over 45 years on Wall Street.
Social Media
Victor Sperandeo
Twitter: vicsperandeo
Amazon Books
www.victorsperandeo.com
Support the show
Subscriber-only episode
Send us a text
Friendly Bear UniversitySubscriber-only episode
Episode 379: DACA recipient & Lawyer Edgar Rodriguez, Esq, joins David Capablanca on the Macro Jabber podcast to talk about financial literacy, investing with the goal of Edgar learning to trade stocks.
Social Media
Edgar Rodriguez
Instagram: erimmigrationlawyer
www.erimmigration.com
Send us a text
Friendly Bear UniversityFrom the publisher's feed
The Friendly Bear™ is a weekly show that focuses on interviewing some of the best traders in the world from different niches. Listeners will be able to take show insights and apply these nuggets of…

3,158 Listeners

3,311 Listeners

1,982 Listeners

2,171 Listeners

1,094 Listeners

1,417 Listeners

8,319 Listeners

933 Listeners

2,638 Listeners

10,100 Listeners

28,985 Listeners

265 Listeners

412 Listeners

2 Listeners

149 Listeners